Factors Associated with RANTES Concentration in Cardiovascular Disease Patients

Joint Authors

Dymicka-Piekarska, Violetta
Koper-Lenkiewicz, Olga M.
Kamińska, Joanna
Lisowska, Anna
Hirnle, Tomasz
Milewska, Anna Justyna

Source

BioMed Research International

Issue

Vol. 2019, Issue 2019 (31 Dec. 2019), pp.1-11, 11 p.

Publisher

Hindawi Publishing Corporation

Publication Date

2019-07-18

Country of Publication

Egypt

No. of Pages

11

Main Subjects

Medicine

Abstract EN

Objective.

The aim of the study was to establish, by means of linear regressions analysis, whether RANTES and CCL2 have a relationship with age, sex, heart rate, ejection fraction, white blood cells count, monocyte count, platelet count, mean platelet volume, hsCRP concentration, creatinine and eGFR value, applied treatments, and coronary risk factors in polish cardiovascular disease patients.

Methods.

Plasma chemokines concentrations were measured by ELISA method (R&D Systems Europe Ltd., Abingdon, England) in 115 cardiovascular disease patients (83 myocardial infarction/AMI and 32 stable angina/SA) and in the control group (N=25).

Results.

Univariate linear regression analysis found that (1) for men mean RANTES plasma level is 1.56 times higher as compared to women; (2) if patient’s age increases by 1 year, the mean RANTES concentration value increases by 1.4%; (3) if CCL2 concentration increases by 10 pg/mL, the mean RANTES concentration value increases by 3.3%; (4) if hsCRP concentration increases by 1 mg/L, the mean RANTES concentration value increases by 1.0%.

By means of multiple linear regression analysis we found that (1) for men the mean plasma RANTES concentration value increases 1.89 times as compared to women; (2) if CCL2 concentration increases by 10 pg/mL, the mean RANTES concentration value increases by 3.4%; (3) if MPV increases by 1 fL, the mean RANTES concentration value increases by 12%, if other model parameters are fixed.

For CCL2 we did not obtain statistically significant linear regression models.

Conclusion.

Due to high variability of obtained CCL2 concentrations, it seems that RANTES better reflects the presence of the atherosclerotic lesion than CCL2.

RANTES as a marker of atherosclerotic process may be an important therapeutic target, and the assessment of RANTES concentration should be interpreted depending on patient’s sex, age, platelet hyperactivity state, hsCRP, and CCL2 concentration.

American Psychological Association (APA)

Koper-Lenkiewicz, Olga M.& Kamińska, Joanna& Lisowska, Anna& Milewska, Anna Justyna& Hirnle, Tomasz& Dymicka-Piekarska, Violetta. 2019. Factors Associated with RANTES Concentration in Cardiovascular Disease Patients. BioMed Research International،Vol. 2019, no. 2019, pp.1-11.
https://search.emarefa.net/detail/BIM-1124270

Modern Language Association (MLA)

Koper-Lenkiewicz, Olga M.…[et al.]. Factors Associated with RANTES Concentration in Cardiovascular Disease Patients. BioMed Research International No. 2019 (2019), pp.1-11.
https://search.emarefa.net/detail/BIM-1124270

American Medical Association (AMA)

Koper-Lenkiewicz, Olga M.& Kamińska, Joanna& Lisowska, Anna& Milewska, Anna Justyna& Hirnle, Tomasz& Dymicka-Piekarska, Violetta. Factors Associated with RANTES Concentration in Cardiovascular Disease Patients. BioMed Research International. 2019. Vol. 2019, no. 2019, pp.1-11.
https://search.emarefa.net/detail/BIM-1124270

Data Type

Journal Articles

Language

English

Notes

Includes bibliographical references

Record ID

BIM-1124270